Hisashi Tsurumi Selected Research

Hisashi Tsurumi Research Topics

Disease

35	Neoplasms (Cancer) 01/2024 - 11/2002
22	Carcinogenesis 10/2017 - 01/2005
21	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 09/2023 - 06/2005
15	Hepatocellular Carcinoma (Hepatoma) 01/2016 - 05/2004
14	Lymphoma (Lymphomas) 11/2023 - 11/2002
12	Non-Hodgkin Lymphoma (Lymphosarcoma) 11/2023 - 06/2002
11	Inflammation (Inflammations) 10/2017 - 01/2005
11	Obesity 01/2015 - 09/2008
10	Body Weight (Weight, Body) 10/2018 - 01/2005
8	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2020 - 08/2007
6	Leukemia 02/2022 - 05/2004
6	Insulin Resistance 01/2015 - 05/2009
5	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 02/2024 - 08/2003
5	Febrile Neutropenia 02/2022 - 06/2008
5	Hematologic Neoplasms (Hematological Malignancy) 01/2017 - 05/2004
5	Multiple Myeloma 01/2016 - 01/2008
5	Aberrant Crypt Foci 07/2014 - 09/2008
5	Liver Cirrhosis (Hepatic Cirrhosis) 02/2013 - 12/2009
5	Colonic Neoplasms (Colon Cancer) 05/2012 - 11/2007
4	Thrombocytopenia (Thrombopenia) 09/2023 - 01/2019
4	Malnutrition (Nutritional Deficiencies) 09/2023 - 12/2012
4	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 02/2022 - 09/2005
4	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 10/2018 - 06/2011
4	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 12/2017 - 01/2009
4	Colorectal Neoplasms (Colorectal Cancer) 09/2012 - 11/2007
3	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 09/2023 - 09/2014
3	Neutropenia 02/2022 - 12/2005
3	Philadelphia Chromosome 02/2022 - 06/2011
3	Stomatitis 01/2021 - 12/2014
3	B-Cell Lymphoma (Lymphoma, B Cell) 04/2020 - 02/2012
3	Pneumonia (Pneumonitis) 01/2020 - 01/2005
3	Cardiotoxicity 10/2018 - 02/2004
3	T-Cell Lymphoma (Lymphoma, T Cell) 12/2017 - 01/2008
3	Pain (Aches) 08/2016 - 01/2008
3	Fibrosis (Cirrhosis) 01/2013 - 12/2009
3	Anemia 01/2011 - 05/2005
3	Fever (Fevers) 11/2010 - 11/2003
2	Hypertension (High Blood Pressure) 01/2024 - 07/2013
2	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 09/2023 - 11/2002
2	HIV Infections (HIV Infection) 01/2023 - 01/2015

Drug/Important Bio-Agent (IBA)

19	Rituximab (Mabthera)FDA Link 11/2023 - 10/2006
19	Cyclophosphamide (Cytoxan)FDA LinkGeneric 09/2023 - 06/2002
18	Prednisolone (Predate)FDA LinkGeneric 01/2020 - 06/2002
17	Vincristine (Oncovin)FDA LinkGeneric 09/2023 - 06/2002
14	Doxorubicin (Adriamycin)FDA LinkGeneric 09/2023 - 02/2004
14	Proteins (Proteins, Gene)FDA Link 10/2020 - 05/2004
9	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 04/2020 - 04/2011
8	pirarubicinIBA 10/2018 - 02/2004
8	KynurenineIBA 12/2017 - 04/2010
8	3,7,11,15- tetramethyl- 2,4,6,10,14- hexadecapentaenoic acidIBA 10/2013 - 05/2004
6	Messenger RNA (mRNA)IBA 01/2016 - 01/2011
6	Diethylnitrosamine (N-Nitrosodiethylamine)IBA 01/2016 - 02/2010
6	AdipokinesIBA 01/2015 - 07/2010
5	AzoxymethaneIBA 07/2014 - 05/2008
5	Retinoid X Receptors (Retinoid X Receptor)IBA 10/2012 - 03/2007
5	epigallocatechin gallate (epigallocatechin-3-gallate)IBA 09/2012 - 05/2008
5	RetinoidsIBA 11/2009 - 05/2004
4	Carboplatin (JM8)FDA LinkGeneric 11/2023 - 06/2002
4	Cytarabine (Cytosar-U)FDA LinkGeneric 09/2023 - 08/2007
4	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 02/2022 - 12/2005
4	Tryptophan (L-Tryptophan)FDA Link 04/2020 - 09/2012
4	Etoposide (VP 16)FDA LinkGeneric 09/2017 - 06/2002
4	TeaIBA 01/2013 - 05/2008
4	Branched-Chain Amino AcidsIBA 12/2012 - 05/2009
4	Interleukin-2 Receptors (IL 2 Receptor)IBA 05/2012 - 11/2002
4	beta CateninIBA 07/2010 - 10/2007
4	Insulin-Like PeptidesIBA 05/2010 - 09/2008
3	Methotrexate (Mexate)FDA LinkGeneric 09/2023 - 06/2002
3	Methylprednisolone FDA LinkGeneric 02/2022 - 08/2003
3	polaprezinc (Z 103)IBA 01/2021 - 12/2014
3	Monoclonal AntibodiesIBA 04/2020 - 06/2005
3	Interleukin-6 (Interleukin 6)IBA 11/2018 - 01/2011
3	Red Fluorescent ProteinIBA 04/2016 - 09/2015
3	EnzymesIBA 01/2016 - 09/2012
3	Antineoplastic Agents (Antineoplastics)IBA 01/2015 - 05/2004
3	LigandsIBA 10/2012 - 05/2004
3	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 10/2012 - 05/2004
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2011 - 07/2002
3	Drinking WaterIBA 06/2011 - 05/2008
3	tyrosine receptor (receptor, tyrosine)IBA 05/2010 - 10/2009
3	Phosphotransferases (Kinase)IBA 05/2010 - 10/2009
3	Retinoid X Receptor alphaIBA 11/2009 - 10/2007
3	Vitamin A (Retinol)FDA LinkGeneric 01/2009 - 05/2004
3	Alitretinoin FDA Link 01/2009 - 11/2007
2	Azacitidine (5 Azacytidine)FDA Link 02/2024 - 01/2023
2	Gemcitabine FDA Link 11/2023 - 01/2009
2	Dexamethasone (Maxidex)FDA LinkGeneric 11/2023 - 09/2023
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 09/2023 - 12/2017
2	Dasatinib (BMS 354825)FDA Link 02/2022 - 10/2018
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2021 - 05/2010
2	ProgranulinsIBA 01/2021 - 10/2017

Therapy/Procedure

24	Drug Therapy (Chemotherapy) 11/2023 - 06/2002
21	Therapeutics 01/2023 - 06/2002
14	Chemoprevention 01/2015 - 05/2004
6	VAP-cyclo protocol 06/2017 - 11/2002
5	Intraperitoneal Injections 01/2016 - 05/2008
4	Hematopoietic Stem Cell Transplantation 01/2021 - 12/2014
3	Injections 01/2023 - 09/2008
3	Radiotherapy 08/2016 - 01/2005
3	Aftercare (After-Treatment) 03/2013 - 01/2009